Document is current
Any future updates will be listed below
-
Authors
Lutz, Konstantin http://orcid.org/0000-0002-6263-467X
Musumeci, Andrea http://orcid.org/0000-0002-2497-0699
Sie, Christopher http://orcid.org/0000-0002-8066-7539
Dursun, Ezgi
Winheim, Elena http://orcid.org/0000-0002-0364-662X
Bagnoli, Johannes
Ziegenhain, Christoph http://orcid.org/0000-0003-2208-4877
Rausch, Lisa
Bergen, Volker http://orcid.org/0000-0003-2486-1473
Luecken, Malte D. http://orcid.org/0000-0001-7464-7921
Oostendorp, Robert A. J. http://orcid.org/0000-0002-4947-0412
Schraml, Barbara U. http://orcid.org/0000-0002-5801-0151
Theis, Fabian J. http://orcid.org/0000-0002-2419-1943
Enard, Wolfgang http://orcid.org/0000-0002-4056-0550
Korn, Thomas http://orcid.org/0000-0002-3633-0955
Krug, Anne B. http://orcid.org/0000-0002-9556-7207
-
Funding
Funding for this research was provided by:
Friedrich-Baur-Stiftung
Deutsche Forschungsgemeinschaft (278529602-SFB1243-A09, 360372040–SFB 1335-P08, 322359157-FOR2599-A03, 278529602-SFB 1243-A14, 210592381-SFB 1054-B06, 408885537-TRR 274-A01, 390857198-EXC 2145, 213904703-TRR 128-A07, 210592381-SFB 1054-A06, 369799452-SFB/TRR 237-B14, 391217598-KR2199/10-1)
Helmholtz Association (Helmholtz AI ZT-I-PF-5-01)
- License Information
-
More Information
Article History
Received: 8 March 2021
Accepted: 24 May 2022
First Online: 16 June 2022
Competing interests
: F.J.T. reports receiving consulting fees from Roche Diagnostics GmbH, Immunai Inc., Singularity Bio B.V., CytoReason Ltd, and Omniscope Ltd Inc., and has an ownership interest in Cellarity, Inc. and Dermagnostix GmbH. VB is a full-time employee of Cellarity Inc. and reports ownership interest in Cellarity Inc.; the present work was carried out at Helmholtz Munich. The other authors declare no competing interests.
